Correspondence:
Editor‐in‐Chief, Brain Pathology
Arie Perry, MD
University of California, San Francisco (UCSF)
Department of Pathology, Division of
Neuropathology
505 ParnassusAvenue, #M551, Box# 0102
San Francisco, CA 94143
Ph: 415‐476‐5236 or 415‐476‐4961
Fax: 415‐476‐7963
E‐mail: Arie.Perry@ucsf.edu
President
Prof Herbert Budka
Institute of Neuropathology
University Hospital Zurich
Schmelzbergstrasse 12
CH‐8091 Zurich
Switzerland
and
Institute of Neurology
Medical University Vienna
AKH 4J, Waehringer Guertel 18‐20
A‐1097 Vienna
Austria
Fax: +43‐1‐40400 5511
E‐mail: herbert.budka@meduniwien.ac.at
Secretary General
Dr David Hilton
Department of Cellular and Anatomical
Pathology
Derriford Hospital
Plymouth PL6 8DH
United Kingdom
Fax: +44‐175‐2763590
E‐mail: davidhilton@nhs.net
Treasurer
Prof Markus Tolnay
Institute of Pathology, Division of
Neuropathology
Schoenbeinstrasse 40
CH‐4003 Basel
Switzerland
Fax: +41‐61‐265‐3194
E‐mail: mtolnay@uhbs.ch
Project Secretary
Dr Homa Adle‐Biassette
Inserm U676, Université Paris Diderot
Hôpital Robert Debré
48 Bd Sérurier
75019 Paris
France
Fax: +33‐1‐40031995
E‐mail: homa.adle@inserm.fr
My standard (and many others') response when a friend informs me that he or she is assuming the role of department chair is: “my sincerest congratulations and condolences”. In other words, this position combines tremendous honors with Herculean responsibilities. I've long been impressed by those special individuals who are not only willing to take on this mantle, but actively seek it! In fact, given that our specialty is such a small one, I've found it astonishing that so many neuropathologists currently serve as general pathology chairs. For these reasons and more, I reacted with mixed emotions to the news that Dr. Tom Montine recently took over the chairmanship position at the University of Washington in Seattle. While I naturally celebrated his irrefutably well‐earned success, reality soon hit when this was followed by the predictable and inevitable announcement that he no longer had sufficient time in his extremely tight schedule to continue as our senior editor for neurodegenerative neuropathology. As the ultimate team player though, he graciously agreed to stay on for a few extra months until we could find a suitable replacement. In fact, I've had the pleasure of working with Tom since January of 2007, as we both began our respective roles for Brain Pathology simultaneously. Given that neurodegenerative neuropathology is one of the largest subspecialty topics, he has personally overseen many of our manuscript submissions over the past 6 years, providing thoughtful and insightful guidance along the way. Additionally, he guest edited the minisymposium “Dementia in Parkinson Disease” for the May 2010 issue (as well as one on eicosanoids and docosanoids in CNS Disease in 2005).
For Tom's exemplary service to our journal, I'd like to personally convey my deepest gratitude! Although he will be sorely missed, I'm pleased to report that he will stay on our editorial board and remains available as a manuscript reviewer. Furthermore, we are now extremely fortunate to find yet another outstanding person to take over this leadership position, Dr. Eileen Bigio. Eileen is particularly well known to our readers, having long served our journal and society as editorial board member and manuscript reviewer. She is the Paul E Steiner Research Professor of Pathology and Neuropathology Medical Director at Northwestern University Feinberg School of Medicine in Chicago, IL, and has extensive experience and expertise in neurodegenerative neuropathology. I can think of no‐one better suited to take over as senior editor and am truly delighted that she accepted our offer. Please help me thank Tom for his dedication and welcome Eileen in her new role.
Arie Perry, MD
